Understanding the molecular mechanisms of statin pleiotropic effects

Adhikari A, Tripathy S, Chuzi S, Peterson J, Stone NJ (2021) Association between statin use and cognitive function: a systematic review of randomized clinical trials and observational studies. J Clin Lipidol 15(1):22-32.e12. https://doi.org/10.1016/j.jacl.2020.10.007

Article  PubMed  Google Scholar 

Alberts AW, Chen J, Kuron G et al (1980) Mevinolin: a highly potent competitive inhibitor of hydroxymethylglutaryl-coenzyme A reductase and a cholesterol-lowering agent. Proc Natl Acad Sci USA 77(7):3957–3961. https://doi.org/10.1073/pnas.77.7.3957

Article  CAS  PubMed  PubMed Central  Google Scholar 

Albert MA, Danielson E, Rifai N, Ridker PM, Investigators ftP, (2001) Effect of statin therapy on C-reactive protein levels the pravastatin inflammation/CRP evaluation (PRINCE): a randomized trial and cohort study. JAMA 286(1):64–70. https://doi.org/10.1001/jama.286.1.64

Article  CAS  PubMed  Google Scholar 

Ali FY, Armstrong PCJ, Dhanji A-RA et al (2009) Antiplatelet actions of statins and fibrates are mediated by PPARs. Arterioscler Thromb Vasc Biol 29(5):706–711. https://doi.org/10.1161/ATVBAHA.108.183160

Article  CAS  PubMed  Google Scholar 

Amarenco P, Bogousslavsky J, Callahan A 3rd et al (2006) High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 355(6):549–559. https://doi.org/10.1056/NEJMoa061894

Article  CAS  PubMed  Google Scholar 

Arnett DK, Blumenthal RS, Albert MA et al (2019) 2019 ACC/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology/American Heart Association Task Force on clinical practice guidelines. Circulation 140(11):e596–e646. https://doi.org/10.1161/CIR.0000000000000678

Article  PubMed  PubMed Central  Google Scholar 

Aviram M, Hussein O, Rosenblat M, Schlezinger S, Hayek T, Keidar S (1998a) Interactions of platelets, macrophages, and lipoproteins in hypercholesterolemia: antiatherogenic effects of HMG-CoA reductase inhibitor therapy. J Cardiovasc Pharmacol 31(1):39–45

Article  CAS  PubMed  Google Scholar 

Aviram M, Rosenblat M, Bisgaier CL, Newton RS (1998b) Atorvastatin and gemfibrozil metabolites, but not the parent drugs, are potent antioxidants against lipoprotein oxidation. Atherosclerosis 138(2):271–280. https://doi.org/10.1016/S0021-9150(98)00032-X

Article  CAS  PubMed  Google Scholar 

Baigent C, Keech A, Kearney PM et al (2005) Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins. Lancet 366(9493):1267–1278. https://doi.org/10.1016/S0140-6736(05)67394-1

Article  CAS  PubMed  Google Scholar 

Baigent C, Blackwell L, Emberson J et al (2010) Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials. Lancet 376(9753):1670–1681. https://doi.org/10.1016/s0140-6736(10)61350-5

Article  CAS  PubMed  Google Scholar 

Baldassarre D, Mores N, Colli S, Pazzucconi F, Sirtori CR, Tremoli E (1997) Platelet alpha 2-adrenergic receptors in hypercholesterolemia: relationship between binding studies and epinephrine-induced platelet aggregation. Clin Pharmacol Ther 61(6):684–691. https://doi.org/10.1016/s0009-9236(97)90104-1

Article  CAS  PubMed  Google Scholar 

Ballantyne CM, Banach M, Mancini GBJ et al (2018) Efficacy and safety of bempedoic acid added to ezetimibe in statin-intolerant patients with hypercholesterolemia: a randomized, placebo-controlled study. Atherosclerosis 277:195–203. https://doi.org/10.1016/j.atherosclerosis.2018.06.002

Article  CAS  PubMed  Google Scholar 

Banach M, Serban C, Sahebkar A et al (2015) Effects of coenzyme Q10 on statin-induced myopathy: a meta-analysis of randomized controlled trials. Mayo Clin Proc 90(1):24–34. https://doi.org/10.1016/j.mayocp.2014.08.021

Article  CAS  PubMed  Google Scholar 

Bays HE, Banach M, Catapano AL et al (2020) Bempedoic acid safety analysis: pooled data from four phase 3 clinical trials. J Clin Lipidol 14(5):649-659.e6. https://doi.org/10.1016/j.jacl.2020.08.009

Article  PubMed  Google Scholar 

Berenson GS, Srinivasan SR, Bao W, Newman WP 3rd, Tracy RE, Wattigney WA (1998) Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study. N Engl J Med 338(23):1650–1656. https://doi.org/10.1056/nejm199806043382302

Article  CAS  PubMed  Google Scholar 

Bergmann A, Ahmad S, Cudmore M et al (2010) Reduction of circulating soluble Flt-1 alleviates preeclampsia-like symptoms in a mouse model. J Cell Mol Med 14(6b):1857–1867. https://doi.org/10.1111/j.1582-4934.2009.00820.x

Article  CAS  PubMed  Google Scholar 

Bernick C, Katz R, Smith NL et al (2005) Statins and cognitive function in the elderly. Cardiovasc Health Study 65(9):1388–1394. https://doi.org/10.1212/01.wnl.0000182897.18229.ec

Article  CAS  Google Scholar 

Bots ML, Elwood PC, Nikitin Y et al (2002) Total and HDL cholesterol and risk of stroke. EUROSTROKE: a collaborative study among research centres in Europe. J Epidemiol Community Health 56(Suppl 1):i19-24. https://doi.org/10.1136/jech.56.suppl_1.i19

Article  PubMed  PubMed Central  Google Scholar 

Bouitbir J, Sanvee GM, Panajatovic MV, Singh F, Krähenbühl S (2020) Mechanisms of statin-associated skeletal muscle-associated symptoms. Pharmacol Res 154:104201. https://doi.org/10.1016/j.phrs.2019.03.010

Article  CAS  PubMed  Google Scholar 

Bourcier T, Libby P (2000) HMG CoA reductase inhibitors reduce plasminogen activator inhibitor-1 expression by human vascular smooth muscle and endothelial cells. Arterioscler Thromb Vasc Biol 20(2):556–562. https://doi.org/10.1161/01.atv.20.2.556

Article  CAS  PubMed  Google Scholar 

Brown MS, Goldstein JL (1986) A receptor-mediated pathway for cholesterol homeostasis. Science 232(4746):34–47

Article  CAS  PubMed  Google Scholar 

Bucher NL, Overath P, Lynen F (1960) beta-Hydroxy-beta-methyl-glutaryl coenzyme A reductase, cleavage and condensing enzymes in relation to cholesterol formation in rat liver. Biochim Biophys Acta 40:491–501. https://doi.org/10.1016/0006-3002(60)91390-1

Article  CAS  PubMed  Google Scholar 

Buchwald H, Varco RL, Matts JP et al (1990) Effect of partial ileal bypass surgery on mortality and morbidity from coronary heart disease in patients with hypercholesterolemia. N Engl J Med 323(14):946–955. https://doi.org/10.1056/nejm199010043231404

Article  CAS  PubMed  Google Scholar 

Canestaro WJ, Austin MA, Thummel KE (2014) Genetic factors affecting statin concentrations and subsequent myopathy: a HuGENet systematic review. Genet Med 16(11):810–819. https://doi.org/10.1038/gim.2014.41

Article  CAS  PubMed  PubMed Central  Google Scholar 

Cannon CP, Braunwald E, McCabe CH et al (2004) Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350(15):1495–1504. https://doi.org/10.1056/NEJMoa040583

Article  CAS  PubMed  Google Scholar 

Cannon CP, Blazing MA, Giugliano RP et al (2015) Ezetimibe added to statin therapy after acute coronary syndromes. N Engl J Med 372(25):2387–2397. https://doi.org/10.1056/NEJMoa1410489

Article  CAS  PubMed  Google Scholar 

Cheeley MK, Saseen JJ, Agarwala A et al (2022) NLA scientific statement on statin intolerance: a new definition and key considerations for ASCVD risk reduction in the statin intolerant patient. J Clin Lipidol. https://doi.org/10.1016/j.jacl.2022.05.068

Article  PubMed  Google Scholar 

Cholesterol Treatment Trialists C (2012) The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials. Lancet 380(9841):581–590. https://doi.org/10.1016/S0140-6736(12)60367-5

Article  CAS  Google Scholar 

Collaboration CRPCHDG, Wensley F, Gao P et al (2011) Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data. BMJ (clin Res Ed) 342:d548–d548. https://doi.org/10.1136/bmj.d548

Article  Google Scholar 

Cudmore M, Ahmad S, Al-Ani B et al (2007) Negative regulation of soluble Flt-1 and soluble endoglin release by heme oxygenase-1. Circulation 115(13):1789–1797. https://doi.org/10.1161/CIRCULATIONAHA.106.660134

Article  CAS  PubMed  Google Scholar 

Daniels LB, Ren J, Kumar K et al (2021) Relation of prior statin and anti-hypertensive use to severity of disease among patients hospitalized with COVID-19: findings from the American Heart Association’s COVID-19 Cardiovascular Disease Registry. PLoS ONE 16(7):e0254635. https://doi.org/10.1371/journal.pone.0254635

Article  CAS  PubMed  PubMed Central  Google Scholar 

Dichtl W, Dulak J, Frick M et al (2003) HMG-CoA reductase inhibitors regulate inflammatory transcription factors in human endothelial and vascular smooth muscle cells. Arterioscler Thromb Vasc Biol 23(1):58–63. https://doi.org/10.1161/01.atv.0000043456.48735.20

Article  CAS  PubMed  Google Scholar 

Döbert M, Varouxaki AN, Mu AC et al (2021) Pravastatin versus placebo in pregnancies at high risk of term preeclampsia. Circulation 144(9):670–679. https://doi.org/10.1161/CIRCULATIONAHA.121.053963

Article  CAS  PubMed  Google Scholar 

Endo A (2010) A historical perspective on the discovery of statins. Proc Jpn Acad Ser B Phys Biol Sci 86(5):484–493. https://doi.org/10.2183/pjab.86.484

Article  CAS  PubMed  PubMed Central  Google Scholar 

Essig M, Nguyen G, Prié D, Escoubet B, Sraer JD, Friedlander G (1998) 3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase fibrinolytic activity in rat aortic endothelial cells. Role of geranylgeranylation and Rho proteins. Circ Res 83(7):683–690. https://doi.org/10.1161/01.re

留言 (0)

沒有登入
gif